FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I)
,
in which R1 is alkyl, C3-6cycloalkyl, pyrazolyl, phenyl, pyridinyl and the said radicals may contain 1-3 substitutes independently selected from a group comprising alkyl, halogen, haloalkyl, halogenalkoxy group; R2 is phenyl and the said phenyl contains 1-3 substitutes independently selected from a group comprising haloalkyl, halogenalkoxy group; R3 represents hydrogen; A represents -(CH2)n- or -S (O)2-; n equals to 1; or its pharmaceutically acceptable salts.
EFFECT: said compounds can be used as inhibitors of hormone-sensitive lipase.
13 cl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2,8-DIAZASPIRO[4,5]DECAN-1-ONE DERIVATIVES, USEFUL AS INHIBITORS OF HORMONE-SENSITIVE LIPASE (HSL) | 2011 |
|
RU2606513C2 |
| AZACYCLIC SPIRO-COMPOUNDS | 2010 |
|
RU2550495C2 |
| AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS | 2011 |
|
RU2567395C2 |
| SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF HSL, EFFECTIVE FOR DIABETES TREATMENT | 2010 |
|
RU2607080C2 |
| TETRAHYDROCINNOLINE DERIVATIVES | 2009 |
|
RU2541533C2 |
| GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
| AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
| OXAZINMONOACYLGLYCERIN LIPASE (MAGL) INHIBITORS | 2019 |
|
RU2794334C2 |
| ARYLETHINYL DERIVATIVES | 2011 |
|
RU2573560C2 |
| IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES | 2007 |
|
RU2439062C2 |
